Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Emyria Ltd ( (AU:EMD) ) is now available.
Emyria has called a general meeting of shareholders to be held in Perth on 1 May 2026, with investors able to attend in person or vote via proxy through multiple electronic and physical channels. In line with Australian corporate law and a broader shift toward digital communication, the company will distribute meeting materials electronically by default, signalling an ongoing move to more efficient, paperless shareholder engagement processes.
Shareholders who have provided email details will receive links to the notice of meeting and explanatory materials online, while others can access documents via Emyria’s website or the ASX announcements platform. The company is urging investors to lodge proxy forms ahead of the deadline if they cannot attend, underlining the importance of participation in corporate decision-making and adherence to formal voting procedures.
The most recent analyst rating on (AU:EMD) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on Emyria Ltd stock, see the AU:EMD Stock Forecast page.
More about Emyria Ltd
Emyria Ltd is an Australian-listed company operating in the healthcare and life sciences sector, with a focus on developing and commercialising medical treatments and services. The company engages with a broad shareholder base and complies with Australian corporate governance and disclosure requirements as part of its ASX listing.
Average Trading Volume: 1,355,833
Technical Sentiment Signal: Hold
Current Market Cap: A$37.91M
Learn more about EMD stock on TipRanks’ Stock Analysis page.